Drugs / dorzolamide/timolol
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01228149 | Aug 2010 → Apr 2014 | glaucoma | Katrin Lorenz | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | dorzolamide/timolol | “Patients receive Cosopt S (dorzolamide/timolol) eye drops starting 28 days before trabeculectomy.” NCT01228149 ↗ |
| Known as | Cosopt S | “Patients receive Cosopt S (dorzolamide/timolol) eye drops starting 28 days before trabeculectomy.” NCT01228149 ↗ |
| Route | Topical | “Patients receive Cosopt S (dorzolamide/timolol) eye drops starting 28 days before trabeculectomy.” NCT01228149 ↗ |